Clinical trial Recruiting at 1 site Observational Ages 18 and up

Hyperinflammation and High Ferritin in Critically Ill Patients

Official title: Hyperinflammation and Hyperferritinemia in Critically Ill Patients: a Retrospective Observational Single-center Analysis

Run by Charles University, Czech Republic · NCT06820905 · Data updated 2026-11-12

This study looks at critically ill patients with signs of high inflammation to see how their condition develops over time.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1962 (estimated)
SponsorCharles University, Czech Republic
Academic / other
Locations1 site (Pilsen, Czech Republic)
StatusRecruiting
StartedOctober 1, 2026
Main results expectedDecember 31, 2027
Study endsJune 30, 2028
Registry record updatedNovember 10, 2026
Trial IDNCT06820905 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults who are critically ill and have signs of hyperinflammation and/or hyperferritinemia, admitted between 2020 and 2024 at the Pilsen site.

Probably not a fit

Patients without evidence of hyperinflammation or ferritin elevation may not benefit from insights drawn from this analysis.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational analysis follows adults with critical illness and hyperinflammation to describe their clinical trajectories and inflammatory patterns. Data from patients admitted between 2020 and 2024 at the Charles University Faculty of Medicine and Teaching Hospital in Pilsen will be examined to identify ferritin levels and inflammatory syndrome characteristics. The goal is to understand how hyperinflammation correlates with outcomes in sepsis and related critical illness. No intervention is applied; the study relies on existing medical records and observational data. Researchers will describe trajectories and phenotypes to inform future research and care strategies.

Why it matters

Potential benefit: Improved understanding of inflammatory patterns in critical illness may guide future treatment approaches and patient management.

How similar studies have gone: Other observational studies have described inflammatory phenotypes in critical illness, showing value in profiling trajectories; this study builds on that approach in a new setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* critically ill patients
* admission between 01.01.2020 and 31.12.2024 (5yrs)

Exclusion Criteria:

* none

Where it's running

  • Faculty of Medicine and Teaching Hospital, Charles University
    Pilsen, Czech Republic, Czechia
    Recruiting

Study contacts

  • Principal investigator: Thomas Karvunidis, MD, PhD — Faculty of Medicine and Teaching Hospital, Charles University, Pilsen, Czech Republic
  • Study coordinator: Thomas Karvunidis, MD, PhD
  • Email: karvunidist@fnplzen.cz
  • Phone: +420776160620

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.